Want to see JP:7780 full AI Analyst Report?
7780 Stock Chart & Stats
¥1597.00
-¥6.00(-0.44%)
At close: 4:00 PM EST
¥1597.00
-¥6.00(-0.44%)
Day’s Range― - ―
52-Week Range¥1,090.00 - ¥2,086.00
Previous CloseN/A
Volume259.20K
Average Volume (3M)246.73K
Market Cap
¥134.07B
Enterprise Value¥171.31K
Total Cash (Recent Filing)¥34.07B
Total Debt (Recent Filing)¥81.55B
Price to Earnings (P/E)18.7
Beta0.75
Next Earnings
Nov 16, 2026EPS Estimate
23.85Next Dividend Ex-DateN/A
Dividend Yield1.59%
Share Statistics
EPS (TTM)96.34
Shares Outstanding76,771,484
10 Day Avg. Volume253,500
30 Day Avg. Volume246,726
Financial Highlights & Ratios
PEG Ratio3.13
Price to Book (P/B)1.34
Price to Sales (P/S)1.01
P/FCF Ratio-37.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,400.00Price Target Upside50.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)94.58
Revenue Forecast (FY)¥132.79B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthRevenue growth across several years indicates expanding demand for Menicon’s contact lenses and eye-care portfolio. A larger revenue base can support broader distribution, continued product investment, and operating scale, although the pack notes that growth has slowed in the last two years.
Strong Gross MarginsSustained gross margins above 50% demonstrate favorable underlying economics in the company’s products and provide capacity to fund research, marketing, and distribution. Margin stability also offers some protection against pressure below the gross-profit line over the next several quarters.
Growing Equity BaseA materially larger equity base strengthens Menicon’s balance-sheet foundation and provides greater capacity to absorb operating volatility or support investment. This capital growth is a durable financial advantage, even though the company’s debt has also increased and returns on equity have moderated.
Bears Say
Persistent Negative Free Cash FlowRecurring negative free cash flow means reported business performance is not consistently converting into cash available for debt reduction, dividends, or reinvestment. Continued investment needs or working-capital volatility could therefore reduce financial resilience and constrain capital allocation over coming quarters.
Higher LeverageRising debt relative to equity reduces financial flexibility and leaves less balance-sheet capacity to fund growth or absorb weaker operating conditions. Meaningful leverage becomes more consequential alongside negative free cash flow, because internally generated cash is less available to reduce obligations.
Compressed ProfitabilityThe decline in net margin shows that strong gross economics have not fully translated into bottom-line profitability. If pressure below gross profit persists, Menicon may generate less earnings from each unit of revenue, limiting internal funding and weakening returns on its expanding equity base.
Menicon Co News
7780 FAQ
What was Menicon Co Ltd’s price range in the past 12 months?
Menicon Co Ltd lowest stock price was ¥1090.00 and its highest was ¥2086.00 in the past 12 months.
What is Menicon Co Ltd’s market cap?
Menicon Co Ltd’s market cap is ¥134.07B.
When is Menicon Co Ltd’s upcoming earnings report date?
Menicon Co Ltd’s upcoming earnings report date is Nov 16, 2026 which is in 52 days.
How were Menicon Co Ltd’s earnings last quarter?
Menicon Co Ltd released its earnings results on Aug 07, 2026. The company reported ¥30.05 earnings per share for the quarter, beating the consensus estimate of ¥16 by ¥14.05.
Is Menicon Co Ltd overvalued?
According to Wall Street analysts Menicon Co Ltd’s price is currently Undervalued.
Does Menicon Co Ltd pay dividends?
Menicon Co Ltd pays a Annually dividend of ¥28 which represents an annual dividend yield of 1.59%. See more information on Menicon Co Ltd dividends here
What is Menicon Co Ltd’s EPS estimate?
Menicon Co Ltd’s EPS estimate is 23.85.
How many shares outstanding does Menicon Co Ltd have?
Menicon Co Ltd has 76,771,484 shares outstanding.
What happened to Menicon Co Ltd’s price movement after its last earnings report?
Menicon Co Ltd reported an EPS of ¥30.05 in its last earnings report, beating expectations of ¥16. Following the earnings report the stock price went up 14.931%.
Which hedge fund is a major shareholder of Menicon Co Ltd?
Currently, no hedge funds are holding shares in JP:7780
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Menicon Co Ltd
Menicon Co., Ltd. (7780) is a Japan-based medical device company focused on vision care. It develops, manufactures, and sells contact lenses and related eye-care products, and is also involved in ophthalmic solutions and associated services supporting contact lens use.
7780 Stock 12 Month Forecast
Average Price Target
¥2,400.00
▲(50.28% Upside)
Technical Analysis
HOYA
―
JINS HOLDINGS
―
Japan Eyewear Holdings Co.,Ltd.
―
Mani, Inc.
―
Seed Co., Ltd.
―









